Events

ISCT 2024

May 29 – June 1, 2024
Vancouver, Canada

We’ll be in booth #604 featuring our TransIT-VirusGEN Transfection Reagent and the RevIT AAV Enhancer.

Be sure to stop by our poster presentation:
Session 1: Wednesday, May 29 19:00-20:30 PT
Poster 851: Universal Enhancer for Improved Viral Titers, Quality and Reduced Production Costs Across Suspension HEK Platforms

BPI International 2024

Septemember 23-26, 2024
Hynes Convention Center
Boston, MA

We’ll be there. Come back for more information!

Recent Past Events

ASGCT 2024

May 7-11, 2024
Baltimore, MD

Calling all Upstream MVPs!

We’ll be in booth #2017 featuring our TransIT-VirusGEN Transfection Reagent and the RevIT AAV Enhancer. Stop by to find out how our platform can give you 2-4X increase in AAV titer, >50% reduction in cost per dose, and 2X doses produced per bioreactor run!

Didn’t get a chance to stop by the poster? Download here!
Enhanced Transfection Complex Performance for AAV Production
Session Date/Time: 5/8/2024 12:00:00 PM
Session Title: Wednesday Posters: AAV Vectors – Product Development Manufacturing and Approval Considerations
Presentation Room: Exhibit Hall
Final Abstract Number: 523

How to build an AAV platform that produces higher titers and percent full capsids

May 1, 2024
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

This CTGI Live30 Webinar will highlight a transfection reagent and enhancer platform, with TransIT-VirusGEN® Transfection Reagent and RevIT™ AAV Enhancer, that increases both AAV titers and percent full capsids by 2- to 10-fold over existing technologies, regardless of serotype, media choice, or suspension HEK cell type. Real-world case study data is provided by CDMO Recipharm, highlighting how their platform achieves high titers and percent full capsids without sacrificing efficiency, and how that further enables reduced cost per bioreactor run and ultimately drives down the cost per patient dose.